VANCOUVER, BC — (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that it is set to join both the Russell 3000®,… Read More
TORONTO, ON — The Coordinated Accessible National (CAN) Health Network and Medtech Canada are pleased to announce a new partnership that will increase growth opportunities for Canadian companies in Canada’s… Read More
In the first cohort of the ongoing Phase 1/2 clinical trial, the first 5 patients to complete protocol-defined islet transplants achieved insulin-independence for ongoing periods of 6 to 38 months…. Read More
Met primary and three key secondary endpoints Data support clinically meaningful and durable pain relief Pharmacokinetic and safety data support potential for chronic and bilateral dosing Company to host conference… Read More
CRH Medical has made a strategic investment in Graphium Health a leading EMR or Electronic Medical Records company focused on Anesthesia Practices. The investment is part of a Strategic Alliance… Read More
